Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Cancer, Metastatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00628810
What this trial is testing

Combination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Federation Francophone de Cancerologie Digestive 86
Not applicableNot Yet RecruitingNCT07754513
What this trial is testing

Circulating Tumor Extracellular Vesicles for Non-Invasive Monitoring of Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 290
Early research (Phase 1)Ended earlyNCT01946646
What this trial is testing

Phase I Study of TS-1 With Concurrent Radiotherapy to Treat Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
National Taiwan University Hospital 10
Not applicableLooking for participantsNCT06893380
What this trial is testing

Combination Therapy of GCNT and Tislelizumab in Advanced Biliary Tract Cancer

Who this might be right for
Locally Advanced Biliary Tract CancersMetastatic Biliary Tract Cancers
CHA University 61
Testing effectiveness (Phase 2)Study completedNCT00922896
What this trial is testing

Trial of Erlotinib, Gemcitabine and Cisplatin in Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Gyeongsang National University Hospital 22
Early research (Phase 1)Ended earlyNCT02132403
What this trial is testing

(PM-01) IMPRIME PGG® With BTH1704 and Gemcitabine for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Illinois at Chicago 3
Early research (Phase 1)Looking for participantsNCT06783569
What this trial is testing

A First-in-Human Escalation and Expansion Study of Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorsGastric CancerEsophagogastric Juction Cancer+1 more
JiaRay Group 94
Testing effectiveness (Phase 2)Study completedNCT03581773
What this trial is testing

Folic Acid Supplement Versus Placebo for Treating Mucositis Adverse Events in Metastatic Renal Cell Carcinoma Patients Receiving Targeted Therapy

Who this might be right for
MucositisStomatitis
Niels Fristrup 84
Large-scale testing (Phase 3)Study completedNCT03231722
What this trial is testing

First Line mFOLFOXIRI + PANITUMUMAB vs mFOLFOX + PANITUMUMAB IN RAS AND BRAF WT METASTATIC COLORECTAL CANCER PATIENTS

Who this might be right for
Metastatic Colorectal Cancer
Gruppo Oncologico del Nord-Ovest 435
Early research (Phase 1)Active Not RecruitingNCT06059001
What this trial is testing

Study to Evaluate the Safety, PK, and Efficacy of the Myc Inhibitor OMO-103 Administered iv in Patients With PDAC

Who this might be right for
Metastatic Pancreatic Cancer
Peptomyc S.L. 26
Testing effectiveness (Phase 2)Study completedNCT00512681
What this trial is testing

A Phase II Study of Irinotecan, Oxaliplatin, Plus TS-1 in Untreated Metastatic Gastric Cancer

Who this might be right for
Stomach Neoplasms
National Cancer Center, Korea 44
Early research (Phase 1)Active Not RecruitingNCT06781983
What this trial is testing

Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Innate Pharma 145
Testing effectiveness (Phase 2)Ended earlyNCT00427973
What this trial is testing

AZD2171 in Treating Patients With Locally Advanced Unresectable or Metastatic Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 17
Not applicableStudy completedNCT05846594
What this trial is testing

Evaluate the Impact of Liquid Biopsy in Participants With a Clinical Diagnosis of Advanced Cancer

Who this might be right for
Metastatic Lung CancerMetastatic Gastrointestinal Cancer
Hoffmann-La Roche 463
Early research (Phase 1)Study completedNCT00873756
What this trial is testing

Dulanermin Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, or Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Genentech, Inc. 23
Testing effectiveness (Phase 2)Study completedNCT01064622
What this trial is testing

Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaRecurrent Pancreatic CarcinomaStage IV Pancreatic Cancer AJCC v6 and v7
National Cancer Institute (NCI) 118
Testing effectiveness (Phase 2)Study completedNCT00003951
What this trial is testing

DX-8951f in Treating Patients With Metastatic Cancer of the Pancreas

Who this might be right for
Pancreatic Cancer
Daiichi Sankyo 37
Post-approval studies (Phase 4)WithdrawnNCT02000739
What this trial is testing

Genetically-informed Therapies for Patients With Metastatic Cancer

Who this might be right for
Metastatic Cancer
Dartmouth-Hitchcock Medical Center
Testing effectiveness (Phase 2)Temporarily pausedNCT00209677
What this trial is testing

Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Hokkaido Gastrointestinal Cancer Study Group 40
Testing effectiveness (Phase 2)Study completedNCT01661972
What this trial is testing

Phase I/II Study of Capecitabine Plus Aflibercept to Treat Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
John Strickler, M.D. 63
Next Page